Old Web
English
Sign In
Acemap
>
authorDetail
>
Michael F. Jarvis
Michael F. Jarvis
AbbVie
Pharmacology
Chemistry
Inflammation
Adenosine kinase
Adenosine
3
Papers
12
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Comparative Bioavailability of Two Formulations of Biopharmaceutical Classification System (BCS) Class IV Drugs: A Case Study of Lopinavir/Ritonavir.
2021
Journal of Pharmaceutical Sciences
Ahmed M. Saeed
Jeffery M. Schmidt
Wijith Munasinghe
Bhadrish K. Vallabh
Michael F. Jarvis
John B. Morris
Nael M. Mostafa
Show All
Source
Cite
Save
Citations (0)
New author guidelines and launch of Short Reports.
2020
Pharmacology Research & Perspectives
Andrew J. Lawrence
Michael F. Jarvis
Show All
Source
Cite
Save
Citations (0)
Therapeutic potential of adenosine kinase inhibition—Revisited
2019
Pharmacology Research & Perspectives
Michael F. Jarvis
Show All
Source
Cite
Save
Citations (12)
1